Skip to search formSkip to main contentSkip to account menu

HGS gene

Known as: Vps27, HRS, HGF-REGULATED TYROSINE KINASE SUBSTRATE 
This gene plays a role in signal transduction and regulation of intracellular protein transport.
National Institutes of Health

Related topics

Related topics

4 relations
Inhibition of Cell ProliferationSignal TransductionVesicle Transport Pathwayhepatocyte growth factor-regulated tyrosine kinase substrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
In-use comparison of blood pressure measurements from an automated blood pressure instrument with those from a mercury sphygmomanometer.
In addition to its ease of use and degree of independence from the subjectivity inherent in measurements made with the mercury… 
2006
2006
Novel in vivo imaging shows up-regulation of death receptors by paclitaxel and correlates with enhanced antitumor effects of receptor agonist antibodies
Susceptibility to apoptosis by tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) is mediated through cognate death… 
2006
2006
HGS-ETR2-A fully human monoclonal antibody to TRAIL-R2: Results of a phase I trial in patients with advanced solid tumors.
3012 Background: HGS-ETR2 is a fully-human high-affinity monoclonal antibody that is agonistic to the Tumor Necrosis Factor… 
2005
2005
HGS-ETR1, a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 1 (TRAIL-R1) in patients with advanced solid cancer: Results of a phase 1…
3052 Introduction: HGS-ETR1 (TRM-1) is a fully human monoclonal antibody that is agonistic to the R1 (TRAIL-R1 or DR4) receptors… 
2005
2005
Phase I and pharmacokinetic study of HGS-ETR2, a human monoclonal antibody to TRAIL R2, in patients with advanced solid malignancies
3055 Background: HGS-ETR2 is a fully-human high affinity monoclonal antibody specific and agonistic to the Tumor Necrosis… 
2005
2005
A phase 1 study of HGS-ETR1, a fully human agonistic monoclonal antibody to the TRAIL-R1, in combination with gemcitabine and cisplatin in subjects with advanced solid malignancies.
2004
2004
197 A phase I and pharmacokinetic (PK) study of an agonistic, fully human monoclonal antibody, HGS-ETR2, to the TNF-alpha related apoptosis inducing ligand receptor 2 (TRAIL R2) in patients with…
1994
1994
cDNA sequences. HGS opens its databanks--for a price.
1994
1994
HGS seeks exclusive option on all patents using its cDNA sequences
1992
1992
Effects of plate preparation on results in microbial mutation assays
Glucose autoclaved in an alkaline phosphate solution (heated glucose + salts, HGS) results in the production of a moiety that is… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)